(Q40444001)

20 September 2017

title

Nonstructural proteins 4A and 4B of hepatitis C virus transactivate the interleukin 8 promoter (English)

1 reference

20 September 2017

0 references

1 reference

Hiroyasu Kadoya

1

1 reference

20 September 2017

Motoko Nagano-Fujii

2

1 reference

20 September 2017

Lin Deng

3

1 reference

20 September 2017

Naoki Nakazono

4

1 reference

20 September 2017

Hak Hotta

5

1 reference

20 September 2017

publication date

1 January 2005

1 reference

Microbiology and Immunology

20 September 2017

published in

1 reference

20 September 2017

volume

49

1 reference

20 September 2017

issue

3

1 reference

20 September 2017

page(s)

265-273

1 reference

Replication of the hepatitis C virus in cell culture

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Type-specific induction of interleukin-8 by adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Inhibition of protein synthesis by the nonstructural proteins NS4A and NS4B of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

The hepatitis C virus nonstructural protein 4B is an integral endoplasmic reticulum membrane protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Complex formation of NS5B with NS3 and NS4A proteins of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Hepatitis C virus NS4A and NS4B proteins suppress translation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Interleukin-8 selectively enhances cytopathic effect (CPE) induced by positive-strand RNA viruses in the human WISH cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-kappa B transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Subcellular localization of hepatitis C viral proteins in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Mutations in Hepatitis C Virus RNAs Conferring Cell Culture Adaptation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Effect of interleukin-8 on production of tumor-associated substances and autocrine growth of human liver and pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Establishment of hepatitis C virus replicon cell lines possessing interferon-resistant phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Hepatitis C virus core protein selectively inhibits synthesis and accumulation of p21/Waf1 and certain nuclear proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Persistent and transient replication of full-length hepatitis C virus genomes in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Is an "a la carte" combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C? The ALGOVIRC Project Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Infection of primary human macrophages with hepatitis C virus in vitro: induction of tumour necrosis factor-alpha and interleukin 8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Inhibition of hepatitis C virus protein expression by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

ER stress regulation of ATF6 localization by dissociation of BiP/GRP78 binding and unmasking of Golgi localization signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Interleukin-8 and hIRH (SDF1-alpha/PBSF) mRNA expression and histological activity index in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Hepatitis C virus NS5A protein interacts with 2',5'-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Physical interaction between hepatitis C virus NS4B protein and CREB-RP/ATF6beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Complex formation between hepatitis C virus core protein and p21Waf1/Cip1/Sdi1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Hepatitis C virus NS5A and subgenomic replicon activate NF-kappaB via tyrosine phosphorylation of IkappaBalpha and its degradation by calpain protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2005.TB03728.X

10.1111/J.1348-0421.2005.TB03728.X

21 January 2018

Identifiers

DOI

1 reference

release_qfgpj2zqqbccxi4w6cmrp4di4q

20 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qfgpj2zqqbccxi4w6cmrp4di4q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference